Jin Medical Closes $105M VIE Acquisition, Issues 70.6M Shares, and Reports H1 2026 Results
ZJYL sits 18% above its 52-week low of $1.641.
Summary
Jin Medical closed its $105 million VIE acquisition of Beijing Tongsheng Technology, issuing 70.6 million shares and adopting charter changes that massively dilute existing holders and entrench insider control. H1 2026 results showed declining revenue and a net loss.
Key Events · M&A and Partnerships · ZJYL
-
Acquisition Closed
On July 21, 2026, Jin Medical completed the VIE acquisition of Beijing Tongsheng Technology, issuing 64,186,456 Class A shares to the seller and 6,418,646 Class A shares to Goldeenridge Ventures as advisory fees — a total of 70,605,102 new shares.
-
Massive Dilution
The 70.6 million shares issued represent a roughly 9x increase over the 7.8 million shares outstanding as of March 31, 2026, diluting existing holders by approximately 90%.
-
Charter Amendments Entrench Control
Shareholders approved a 27x increase in Class B voting rights (from 30 to 800 votes per share) and a 300x increase in authorized Class A shares, cementing insider control and enabling further dilutive issuances.
-
H1 2026 Financials Decline
Revenue fell 9.7% to $8.9 million, and the company swung to a net loss of $0.2 million from a small profit a year earlier, driven by lower wheelchair sales and higher R&D costs.
Analysis · ZJYL · Industrial Applications And Services
Jin Medical completed its highly dilutive acquisition of Beijing Tongsheng Technology, issuing 64.2 million Class A shares to the seller and 6.4 million shares to its financial advisor. The deal, valued at $105 million, was priced at the lowest VWAP over 90 days, implying a deep discount to recent trading levels. Combined with the newly adopted charter amendments — a massive increase in authorized shares and super-voting rights for Class B holders — existing shareholders face severe dilution and a permanent shift in control dynamics. The simultaneous release of H1 2026 results shows a 9.7% revenue decline and a swing to a net loss, underscoring the operational challenges that likely drove the need for this transformative but costly transaction.
At the time of this filing, ZJYL was trading at $1.93 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $15.2M. The 52-week trading range was $1.64 to $17.18. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.